Thursday, 30 April 2020

Between beta Thalassaemia Trait and HBE trait which one relatively easy to manage in pregancy period/ labour period??


. What are the types of globin chains attached to haem pigment ?? We know that haemoglobin is a terameric protein, composed of two kinds of globin chains.  Therefore there are total four globin chains are attached to each haem molecule. Thalassaemia by definition is quantitative diminution of synthesis of one or two type’s globin chains. But by haemoglobinopathies we understand there are structurally abnormal globins and such abnormal globin chains may affect either    β, α, γ or Õ chains. These are the four types of globin chains. When to think of abnormal haemoglobin after going through peripheral smear? Or say Thalassemia??
1)                       Microcytosis disproportionate to the degree of anemia. 2) then one should enquire any positive family history or lifelong personal history of microcytic anemia 3) Abnormal red blood cell morphology with microcytes acanthocytes and target cells
Q. What to diagnose B thalassemia?? Ans:-  In B thalassemia elevated levels of hemoglobin A2 or F
General Considerations : The thalassemia are hereditary disorders characterized by reduction in the synthesis of globin chains. Reduced globin chain synthesis causes reduced hemoglobin synthesis and eventually produces a hypochromic microcytic anemia because of defective hemoglobinization of red blood cells. Thalassemias can be considered among the hypoproliferative anemias the hemolytic anemias and the anemias related to abnormal hemoglobin since all of these factors play a role in pathogenesis.
  
. .Q. 2: What are the three usual types of globin  chains are observed in persons who carry near normal globin moiety?? Ans:   in adults there are normally  three kinds of globin chains: and amount of each globin varies person to person but the usual range is as follows:- is HbA0  (α-2,  β -2 chains    )  and this is  comprises about 95-97% of all globin moiety in a haemoglobin molecule. :  HbA2 by contrast have following globin pattern (α-2 and Õ2 chains) and it comprises     normally  about 2-3% of all  globins in haemoglobin. Lastly (third variety) is   HbF  (comprises of  two α-chains  and 2  γ chains ). HbF  is < 2% of all globin  chains. When only one a- globin chain is present the patient has hemoglobin H disease. This is a chronic hemolytic anemia of variable severity. Physical examination will reveal pallor and splenomegaly. Although affected individuals do not usually require transfusions they may do so during periods of hemolytic exacerbation caused by infection or other stresses. When all four a-globin genes are deleted the affected fetus is stillborn as a result of hydrops fetalis.


What is the difference between Thalassaemia & Haemoglobinopathies:-:-We all know that: the thalassemia are due to a quantitative defect in the globin chain production. Haemoglobinopathies result from a) structural defect in the globin gene, c)  whereas the average frequency of Hb-S and Hb-D is 4.3% and 0.86%, respectively in Indian population . HbS, HbE, and Hb D are prevalent in India..
The genetics of normal goblin synthesis: What about alpha chains? Such chains are governed by 4 genes all of them are located at Chromosome 16. What about beta chains production?: Such are controlled only by 2 genes which are located at Chromosomes 11. Beta thalassaemia is a mutation disorder.(Alpha thalassaemia is a deletion disorders). Normal adult hemoglobin is primarily hemoglobin A which represents approximately 98% of circulating hemoglobin. Hemoglobin A is formed from a tetramer two a chains and two B chains – and can be designated a2 B2 . Two copies of the a globin gene are located on chromosome 16 and there is no substitute for  a globin in the formation of hemoglobin . The B globin gene resides on chromosome 11 adjacent to genes encoding the B like globin chains g and y . The tetramer of a2 g2 forms hemoglobin A2 which normally comprises 1-2 % of adult hemoglobin . The tetramer a2 y2 forms hemoglobin F which is the major hemoglobin of fetal life but which comprises <1% of normal adult hemoglobin .

Hemoglobin chain disorders are principally tow kinds Type A disorders are quantitative in nature but no structural defect in globin synthesis (thalassemia group of disorders) : There is no abnormality in structure of globin chains. All the four globin chains are structurally normal but the production rate of any one is at slower speed at factory (Quantitatively low globin chains usually one chain is affected) . It is a quantitative defect of the globin synthesis and are due to genetic defect. .Such genetic defect (inactivation-mutant genes )  may involve either α,  β or γ β chains .By contrast the beta chain of globin  manufacturing:-There are two Varity of  β thalassemia  :    β thalassemia major implies both the genes  designated for    β chain  synthesis are defective (derived one from each parent) and   β thalassemia minor implies only one   gene  entrusted with synthesis of   β globin  is defective .
Thalassaemia Diagnostic dilemma:-Confirmation   of diagnosis must be done in conjunction with 1) Parental Screening, 2)  DNA  study  &  3) blood picture B-12   deficiency .4)  Severe Iron  deficiency can   lead to borderline HbA2’s . The Hb A2 results   must be repeated after correcting the   Iron  deficiency.  Normally a man/ woman of beta Thalassemia minor will exhibit HbA of 80-95%: HBA2 of 4-10% and HBF will be usually in the range of 1-5%.. In cases of all thalassaemia  Family studies must be done  to  confirm  the compound heterozygous  conditions  of thalassaemia &  a haemoglobinopathies   together  or when the  haemoglobinopathies coexist. The results    cannot be suggestive of a particular diagnosis  if the sample  was analyzed    following   a blood transfusion , Most haemoglobin variants   are clinically silent. In beta thalassemia carrier 1) to supplement full dose of F acid2) If ferritin is low then oral Fe is indicated but by and large Blood transfusion is contraindicated,. Unless Hb is < 8Gm near term.

What about HBE prevalence: - This  gene frequency in north eastern regions of India has been reported to be 10.9%. In a study, the prevalence of sickle cell disorders was found to vary from 2.4% to 5.6% among the tribes of Orissa in eastern India / in central India, the prevalence of sickle cell disorders was observed to be 5.7% among children.
What about the terminology of HPLC? Hemoglobin separates into major and minor hemoglobin’s when subjected to CE-HPLC. The order of elution of the various components is HbA1a, HbA1b, Hb, LA1c/CHb-1, LA1c/CHb-2, HbA1c, P3 (Hb component), HbA0, and HbA2. The minor hemoglobin’s A1a, A1b, A1C, F1, and the P3 component are posttranslational modifications of the globing chains. HbA2, a minor hemoglobin, however, is composed of two alpha and two delta chains. HbA0 and Hb are the major hemoglobin’s in a normal  population.
What about HbA2  level ?? What is β-thalassemia trait?  An elevated HbA2 with an average value of about 5%, along with microcytic hypo chromic indices, is characteristic of β-thalassemia trait in β-thalassemia major, in addition to a markedly microcytic hypo chromic blood picture; there are elevated HbA2 and elevated Hb ranging from 10 to 90% .He trait is diagnosed by the presence of a high HbA2 (E+A2), approximately 30% Homozygous He patients have approximately 90% HbE+A2 with minor elevation of Hb . HbE+A2 levels of 40–60% with marked elevation of Hb are seen in He-β-thalassemia Hobs is around 40% in sickle cell trait, 90–95% in sickle cell anemia’s (which varies inversely with Hb proportion), and less than 50% in sickle β-thalassemia .Approximately less than 50% of abnormal hemoglobin is seen in Hb traits
The present study highlights the detection of the haemoglobinopathies and thalassemia by CE-HPLC.


Type B disorders are called Haemoglobinoathies? HbE Disorders (E Trait, EE, E β-Thalassemia)
Comparing all the HbE disorders, it is seen that the lowest hemoglobin as well as the highest proportion of HbF is seen in HbE β-thalassemia The single case of HbSE disorder had a hemoglobin of 10.1 gm%, thalassemic indices with MCV of 71fl, MCH of 23.1 pg, 36.7% of HbA2+HbE, and 2.8% of HbF.

Q. 3: What are the different kinds of haemoglobinopathies??  There is mutation of any one of the total 400 genes involved in the synthesis of globin chains.   Haemoglobin variants are due to manufacture of abnormal globins usually one chain is affected. Such structurally abnormal  haemoglobin are collectively called as Haemoglobinopathies .Most important example is sickle cell disease, trait and  HbC  diseases, Hb C disease, HbE trait, (20-35% HBE structurally).However HBE trait may be very rarely combined with beta trait when it should be investigated as Thalassaemia major.(prenatal testing like Thalassaemia  major is important & recommended).
In sickle cell trait:- There is mutation of any one of the total 400 genes involved in the synthesis of globin chains.  It is due to substititution of 1 amino acid for another one. Sometimes it may be due to deletion of a portion of amino acid sequence: He/ She may complain of painless haematuria. Such trait has no anemia and normal RBC morphology but higher rate of UTI / Splenic infarct.
What about Sickle Cell disease? It is basically a chr hemolytic anemia and one glutamic acid is replaced by valine at position of 6 of the beta globin  chain. HBs? Beta thalassaemia are not uncommonly present in Indian population (South India in particular) and in Africa. Mild jaundice, cholelithiasis, splenomegaly are common as is retinopathy and stroke.. Normocytic normochromic anemia with target cells, sickled cells and ovalocytes.

.
Which method may be best used for detection of structural abnormality of globin chains of Haemoglobin?? Ans:- Most haematologist believe that  cation exchange-high performance liquid chromatography (CE-HPLC) is increasingly being used as a first line of investigation for haemoglobinopathies and thalassemia. Together with a complete blood count, the CE-HPLC is effective in categorizing haemoglobinopathies as traits, homozygous disorders and compound heterozygous disorders.

What is the prevalence  of different thalassaemia and Haemoglobinopathies  in India?? Ans: The commonest disorder in  India varies from state to state. In one study concentrating chiefly South Indian population it was observed that  1)  β-thalassemia trait (37.9%),  2) HbE trait (23.2%), 3) homozygous HbE (18.9%), 3)  HbS trait (5.3%), 4) HbE β-thalassemia (4.6%), 5) HbS β-thalassemia (2.5%) ,6)  β-thalassemia major (2.3%),7)  HbH (1.6%), 8)  homozygous HbS (1.4%), and HbD trait (0.7%).



When we wil designate as    Thalassemia Trait?? The Thalassemias are described as trait when there are laboratory features without significant clinical impact and  when there is a red blood cell transfusion requirement or other moderate clinical impact and major when the disorder is life threatening.
What is  α  Thalassaemia ?? Ans: a-Thalassemia is due primarily to gene deletion causing reduced a-globin chain synthesis. Since all adult hemoglobins are a containing a – thalassemia produces no change in the percentage distribution of hemoglobins A,  A2 and F. In severe forms of a- Thalassemia excess B chains may form a B 4 tetramer called hemoglobin H.
What causes  β Thalassemia  ?? B-Thalassemias are usually caused by point mutations rather than deletions. These mutations result in premature chain termination or in problems with transcription of RNA  and ultimately result in reduced or absent B-globin chain synthesis . The molecular defects leading to B- thalassemia are numerous and heterogeneous. Defects that result in absent globin chain expression are termed B whereas those causing reduced synthesis are termed B. The reduced B-globin chain synthesis in B-thalassemia results in a relative increase in the percentages of hemoglobins A2 and F compared to hemoglobin A as the B like globins substitute for the missing B chains. In the presence of reduced B chains the excess a chains are unstable and precipitate leading to damage of red blood cell membranes. This leads to both intramedullary and peripheral hemolysis. The bone marrow becomes hyperplastic under the drive of anemia and ineffective erythropoisies resulting from the intramedullary destruction of the developing erythroid cells. In cases of severe thalassemia the marked expansion of the erythroid element n the bone marrow may cause severe bony deformities osteopenia and pathologic fractures.
How do we diagnose Beta Thalassaemia?? What may be preliminary Clinical Findings?
A.                    Symptoms and Signs
The a- thalassemia syndromes are seen primarily in persons from southeast Asia and China and less commonly in blacks. Normally adults have four copies of the a-globin chain. When three a- globin genes are present the patient is hematologically normal. When two a- globin genes are present the patients is said to  have a thalassemia trait one form of thalassemia minor. These patients are clinically normal and have a normal life expectancy and performance status with a mild microcytic anemia.

Global Location: Zone of high prevalence:-B-Thalassemia primarily affects persons of Mediterranean origin and to a lesser extent Asians and blacks. Patients homozygous for B- thalassemia have thalassemia major . Affected children are normal at birth but after 6 months when hemoglobin synthesis switches from hemoglobin F to hemoglobin A, develop severe anemia requiring transfusion. Numerous clinical problems ensue including growth failure bony deformities hepatosplenomegaly and jaundice. The clinical course is modified significantly by transfusion therapy  but the transfusional iron overload results in a clinical picture similar to hemochromatosis with heart failure cirrhosis and endocrinopathies usually after more than 100 units of red blood cells. These problems develop because of the body’s inability to excrete the iron from transfused red cells. Before the application of allogeneic stem cell transplantation and the development of more effective forms of iron chelation death from cardiac failure usually occurred between the ages of 20 and 30 years . This has been profoundly changed by the early application of transplantation .
What do U man by homo/heterozygosis?? Patients homozygous for a milder form of B- thalassemia have Thalassaemia intermedia. These patients have chronic hemolytic anemia but do not require transfusions except under periods of stress. They also may develop iron overload because of periodic transfusion. They survive into adult life but with hepatosplenomegaly an bony deformities minor and a clinically insignificant microcytic anemia.
Is it possible to diagnose by prenatal methods? When such tests become necessary? What is these nionivaaive method now available for diag Thal major( Prenatal diagnosis is available and genetic counseling should be offered and the opportunity for prenatal diagnosis discussed What are the informations we gather from cell free DNA (foetal cells citculatimg in maternal blood) ?? .
What do U expect if U send the blood to A REPUTED LAB? Have lab reports of this indoor pt  been supplied by te  invigilators to you, my  dear candidate?? Have seen the Laboratory Findings already done?
What is α-Thalassemia trait- Patients with two a- globin genes have mild anemia with hematocrits between 28% and 40% . The MCV is strikingly low despite the modest anemia and the red blood count is normal or increased. The peripheral blood smear shows microcytes hypochromic occasional target cells and acanthocytes . The reticulocytes count and iron parameters are normal. Hemoglobin electrophoresis will show no increase in the percentage of hemoglobin A2 or F and no hemoglobin H  a- thalassemia trait is thus usually diagnosed by exclusion . Genetic testing to demonstrate a- globin gene deletion is available only in research laboratories.
2 A very rare diseases  is HB H diseases? Have U heard the name of it?? Hemoglobin H disease- These patients have a more marked hemolytic anemia with hematocirts between 22% and 32%.The MCV is remarkably low and the peripheral blood smear is markedly abnormal with hypochromia microcytosis target cells and poikilocytosis. The reticulocye count is elevated . Hemoglobin electdrophoresis will show the presence of fast migrating hemoglobin which comprises 10-14 % of the hemoglobin. A peripheral blood smear can be stained with supravital dyes to demonstrate the presence of hemoglobin H.
 What U do know about β-Thalassemia minor-not an uncommon condition in N E India??  – As in a thalassemia trait these patients have a modest anemia with hematocrit between 28% and 40%  . The MCV ranges from 5 to 75 ft and the red blood cell count is normal or increased. The peripheral blood smear is mildly abnormal with hypochromia  Microcytosis and target cells. In contrast to a – thalassemia basophilic stippling may be present. The reticulocytes count is normal or slightly elevated. Hemoglobin electrophoresis may show an elevation of hemoglobin A2 to 4-8% and occasional elevations of hemoglobin F to 1-5%
4:-Thalassemia major – B- Thalassemia major produces severe anemia and without transfusion the hematocrit showing severe poikilocytosis hypochromia microcytosis target cells basophilic stippling and nucleated red blood cells. Little or no hemoglobin A is present Variable amounts of hemoglobin A2 are seen and the major hemoglobin present a hemoglobin F.
Thal trait?  Treatment
Patients with mild thalassemia require no treatment and should be identified so that they will no be subjected to repeated evaluations and treatment for iron deficiency. Patients with hemoglobin H disease should take folate supplementation and avoid medicinal iron and oxidative drugs such as sulfonamides. Patients with severe thalassemia are maintained on a regular transfusion schedule and receive folate supplesmentation. Splenectomy is performed f hypersplensim causes a marked increase in the transfusion requirement . Patients with regular transfusion requirements should be treated with iron chelation in order to prevent life limiting organ damage from iron overload. Subcutaneous infusion of deferoxamine has largely been replaced by the oral agent deferasirox.
What about Marrow Transplantation?? Allogenic bone marrow transplantation is the treatment of choice for B- thalassemia major. Children who have not yet experienced iron overload and chronic organ toxicity do well with long term survival in more than 85% of cases.
General Considerations.
 U are doing well . Wee the examiners are happy with your answer. But can U tellus what do U mean by the term  sideroblastic anemia ?? Sideroblastic anemias are a heterogeneous group of disorders in which hemoglobin synthesis is reduced because of failure to incorporate heme into protoporphyrin to form hemoglobin. Iron accumulates particularly in the mitochondria. The disorder is usually acquired it is most often a subtype of myelodysplasia . Other causes include chronic alcoholism and lead poisoning.
 What are the Clinical Finding  of Sideroblastic anemias?? Any idea dear examinee??
Patients have no specific clinical features other than those related to anemia. The anemia is usually moderate with hematocrits of 20-30% but transfusions may occasionally be required. Although the MCV is usually normal or slightly increased it may occasionally be low, leading to confusion with iron deficiency. However, serum iron level is elevated and transferrin is high. The peripheral blood smear characteristically shows a dimorphic population of red blood cells, one normal and one hypochromic. In cases of red poisoning, coarse basophilic stippling of the red cells is seen and the serum lead levels will be elevated. The diagnosis is made by examination of the bone marrow. Characteristically, there is marked erythroid hyperplasia, a sign of ineffective erythropoieis (expansine of the erythroid compartment of the bone marrow that dose not result in the production of reticulocytes in the peripheral blood ). The Prussian blue iron stain of the bone marrow shows a generalized increase in iron stors and the presence of ringed sideroblasts, which are cells with iron deposite encircling the red cell nucleus. Occasionally, the anemia is so severe that support withtransfusion is required. These patients usually do not respond will to erythropoietin therapy, especially when transfusion requirements are significant


No comments:

Post a Comment